retatrutide mechanism triple agonist gip glp-1 glucagon receptor LY3437943, a novel glucagon, GIP, and for glycemic control and weight loss: From discovery to clinical proof of concept Frontiers | Mechanisms of action
Description
While searches for Ozempic dropped 26.1%, other weight loss drugs drove much of the growth: Retatrutide increased by 196.1%, Tirzepatide jumped 138.3% and Zepbound climbed 109.2%

Undissolved particles mean incomplete reconstitution, which means inaccurate dosing
Drug Interactions Can Be Dangerous GLP-1 medications can interact with other drugs you're already taking, including medications for diabetes, blood pressure, and other chronic conditions

The 90-degree rule Insert the needle straight in at a 90-degree angle
Clinical trials showed folks could lose 15-20% of their body weight with these, plus lifestyle changes
